Qube Research & Technologies (QRT)
VYNE icon

Qube Research & Technologies (QRT)’s VYNE Therapeutics VYNE Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio VYNE Stock Details VYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-889
Closed -$110K – 2854
2021
Q1 		$110K Buy
+889
New +$129K ﹤0.01% 1733
2020
Q4 		– Sell
-186
Closed -$22K – 2250
2020
Q3 		$22K Buy
+186
New +$21.7K ﹤0.01% 1582

Other funds holding VYNE

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return

Qube Research & Technologies (QRT)'s VYNE Position: Q2 2021 in Review

Qube Research & Technologies (QRT) sold out of VYNE Therapeutics (VYNE) in Q2 2021, closing a stake of 889 shares — an estimated $110K sold.

Qube Research & Technologies (QRT) first reported a position in VYNE in Q3 2020 and held it in 2 quarters. The position peaked at $110K in Q1 2021. 72 funds tracked by Wall St. Rank hold VYNE as of Q2 2021.

  • Qube Research & Technologies (QRT) reported no remaining VYNE Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 889 VYNE Therapeutics shares in Q2 2021, an estimated $110K.
  • Qube Research & Technologies (QRT) first reported a position in VYNE Therapeutics in Q3 2020 and held it in 2 quarters.
  • Qube Research & Technologies (QRT)'s VYNE Therapeutics position peaked at $110K in Q1 2021.
  • 72 funds tracked by Wall St. Rank held VYNE Therapeutics as of Q2 2021.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2021, filed 13 Aug 2021.